Incyte | INCY - EPS Earnings Per Share

Stock Price
105.49
Daily Change
2.89 2.82%
Monthly
-1.10%
Yearly
40.75%
Q1 Forecast
96.99

Incyte reported $2.26 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 1.93 1.43 Feb/10 2026
FY2025Q3 Sep/2025 2.26 1.58 1.07 Oct/28 2025
FY2025Q2 Jun/2025 1.57 1.40 -1.82 Jul/29 2025
FY2025Q1 Mar/2025 1.16 1.01 0.64 Apr/29 2025
FY2024Q4 Dec/2024 1.43 1.51 1.06 Feb/10 2025




Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.78 0.15 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Exelixis USD 0.78 0.03 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
MacroGenics USD 0.27 0.84 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -0.51 1.62 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Novartis USD 2.02 0.04 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025